Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gastrointestinal tumors
Pharma
FDA approves Shorla's oral liquid version of Novartis' Gleevec
Shorla has scored an FDA nod for its strawberry-flavored drink version of Novartis' Gleevec.
Kevin Dunleavy
Nov 26, 2024 11:18am
FDA adds uses for Merck's Keytruda, Pfizer and Astellas' Xtandi
Nov 17, 2023 11:18am
Evonik signs on to manufacture Phathom's GI treatment
Oct 11, 2022 9:35am
AstraZeneca's Imfinzi snags an I-O first before key FDA verdicts
Sep 6, 2022 11:22am
